Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hana Hrobat
Observed name:
Hana HROBAT
Institution:
University of Ljubljana
Observed institutions:
University of Ljubljana,
Ljubljana University Medical Centre
ORCID:
0009-0004-0940-720X
Observed ORCID:
0009-0004-0940-720X
OpenAlex ID:
A5028821707
Incidence of postpartum depression after treatment of postpartum anaemia with intravenous ferric carboxymaltose, intravenous ferric derisomaltose or oral ferrous sulphate: A randomized clinical trial
2023
·
Lea Bombač Tavčar
, Hana Hrobat
, et al.
·
European Journal of Obstetrics & Gynecology and Reproductive Biology X
·
9
Wellbeing Forecasting in Postpartum Anemia Patients
2023
·
David Susič
, Lea Bombač Tavčar
, et al.
·
Healthcare
·
9
PDF
Maternal Fatigue after Postpartum Anemia Treatment with Intravenous Ferric Carboxymaltose vs. Intravenous Ferric Derisomaltose vs. Oral Ferrous Sulphate: A Randomized Controlled Trial
2024
·
Lea Bombač Tavčar
, Hana Hrobat
, et al.
·
Journal of Clinical Medicine
·
5
PDF
Impact of postpartum anemia treatment with intravenous ferric carboxymaltose, intravenous ferric derisomaltose or oral ferrous sulphate on maternal fatigue: a randomized clinical trial
2023
·
Lea BOMBAČ TAVČAR
, Hana HROBAT
, et al.
·
1
PDF
Risk of Hypophosphatemia Following Postpartum Anemia Treatment with IV Ferric Carboxymaltose, IV Ferric Derisomaltose, and Oral Ferrous Sulfate
2025
·
Lea Bombač Tavčar
, Miha Lučovnik
, et al.
·
Journal of Clinical Medicine
PDF
Show more works
View as search
Works count:
5
Citation count:
24
H-index:
3
I10-index:
Year
Topic
Type